The European Commission (EC) and the Department of Biotechnology (DBT), Government of India have provided grants to 5 years’ program (2021-2025) on the development of next-generation influenza vaccine. The first of its kind of collaborative efforts between continents will address the present scientific obstacles on influenza vaccine development and work together to fill in the research gaps for the development of next-generation influenza vaccines. Three projects viz., ENDFLU, INCENTIVE, and INDIGO have been awarded jointly by EU and DBT towards achieving this aim.  THSTI is a part of all these three projects and will lead INDIGO.